Frequently Asked Questions
The global Parenteral Nutrition Market was valued at USD 6.8 Billion in 2022.
The Parenteral Nutrition Market is expected to grow at a CAGR of 6.50% between 2023 and 2030, reaching USD 10.5 Billion in 2030.
The single-dose amino acid solution segment held the greatest market share of more than 30.5% in 2022.
The adult segment contributes the rest to the demand for Parenteral Nutritions.
The hospitals end-use category accounted for the highest CAGR in the global market.
In 2022, North America held the biggest market share of more than 41%.
The top players include Baxter, Otsuka Pharmaceutical Factory, Inc., Forbes Media LLC. Other major players include B.Braun Melsungen AG, Fresenius SE & Co. KGaA,Grifols S.A and Pfizer, Inc.
Chronic illness Prevalence is rising, as is the demand for home parenteral nutrition is the major market drivers.
The key market restrictions are that parenteral nutrition products are expensive and raise the risk of infections and consequences; alternatives are available.
Increasing Use in Critical Care Settings and an Ageing Population are the major opportunities in the Parenteral Nutrition industry.